Alembic Pharma Receives U.S. FDA Approval For Breast Cancer Injection

NDTV Profit

Published On

27 Dec 2022, 01:37 PM IST

Last Updated On

27 Dec 2022, 01:37 PM IST

#AlembicPharma receives U.S. #FDA's approval for Fulvestrant Injection, which is used in treatment of breast cancer.CFO Rajkumar Kumar Baheti shares what it means for the company. #BQLive

RECOMMENDED FOR YOU

Granules India's API Facility In Telangana Gets FDA Observation

timelogo

Natco Pharma's Division In Hyderabad Gets Seven FDA Observations

timelogo

Sun Pharma Share Price Fell Nearly 2% After US FDA Issues Eight Observations

timelogo

Glenmark Pharma To Launch Cancer Treatment Drug Zanubrutinib After DGCA Approval

timelogo